Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Letters|May 25, 2010
A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathwayHong-Lei Tian, Ting Yu, Nai-Ning Xu, et al.
International Journal of Oncology|June 12, 2012
Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signalingRong-Rui Liang, Shu Zhang, Jun-An Qi, et al.
Orthopaedic Surgery|October 31, 2019
Comparison of Superior-Level Facet Joint Violations Between Robot-Assisted Percutaneous Pedicle Screw Placement and Conventional Open Fluoroscopic-Guided Pedicle Screw PlacementQi Zhang, Yun-Feng Xu, Wei Tian, et al.
Cancer Research|December 25, 2002
Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathwayJia-Ju Bao, Xiao-Feng Le, Rui-Yu Wang, et al.
World Neurosurgery|April 29, 2019
Comparison of the One-Time Accuracy of Simulated Freehand and Navigation Simulated Pedicle Screw InsertionYun-Feng Xu, Qi Zhang, Xiao-Feng Le, et al.
Cancer Research|June 19, 2008
Role of PELP1/MNAR signaling in ovarian tumorigenesisChakravarty Dimple, Sujit S Nair, Rajib Rajhans, et al.
Cancer|February 29, 2012
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patientsEun-Jung Jung, Libero Santarpia, Juyeon Kim, et al.
Plos One|November 13, 2012
Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcomeMichelle K Y Siu, Daniel S H Kong, Hoi Yan Chan, et al.
Histopathology|December 20, 2011
Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survivalFung Zhao, Michelle K Y Siu, LiLi Jiang, et al.
Molecular Cancer|December 24, 2010
Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancersLili Jiang, Michelle K Y Siu, Oscar G W Wong, et al.
Pageof 4